9 octobre 2016

Essais cliniques falsifiés

Quelle nouvelle alarmante:

Pharmaceutical companies in China are making up the results of their clinical trials in order to get approval to mass produce drugs, according to a report conducted by the country’s State Food and Drug Administration (SFDA). Staggeringly, the government-run investigation found that up to 80 percent of all data published by Chinese drug manufacturers may have been falsified.

(...) this highly immoral behavior can have potentially disastrous consequences for those who end up using these drugs. For instance, the report found that many companies were deliberately underreporting harmful side effects experienced by participants in their trials, in the hope of gaining the necessary health and safety approval. 



Aucun commentaire: